The two-faced nature of small heat-shock proteins: Amyloid fibril assembly and the inhibition of fibril formation. Relevance to disease states

Small Stress Proteins and Human Diseases

Volumn , Issue , 2011, Pages 189-211

  Ecroyd, Heath ^a,b   Meehan, Sarah ^c   Carver, John A ^b  

^a UNIVERSITY OF WOLLONGONG   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895392709     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (113)

1. Horwich, A. (2002) Protein Folding in the Cell. Academic Press, San Diego, USA.
2. Harding, J. J. (1991) Cataract: Biochemistry, epidemiology and pharmacology. Chapman and Hall, London.
3. Dobson, C. M. (1999) Protein misfolding, evolution and disease. Trends Biochem Sci. 24, 329-332.
4. Dobson, C. M. (2001) The structural basis of protein folding and its links with human disease. Philos Trans R Soc Lond B Biol Sci. 356, 133-145.
5. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 75, 333-366.
6. Treweek, T. M., Morris, A. M. and Carver, J. A. (2003) Intracellular protein unfolding and aggregation: the role of small heat-shock chaperone proteins. Aust J Chem. 56, 357-367.
7. Ecroyd, H. and Carver, J. A. (2008) Unraveling the mysteries of protein folding and misfolding. IUBMB Life 60, 769-774.
8. Horwitz, J. (1992) Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci U S A.. 89, 10449-10453.
9. Carver, J. A., Rekas, A., Thorn, D. C. and Wilson, M. R. (2003) Small heat-shock proteins and clusterin: intra- and extracellular molecular chaperones with a common mechanism of action and function? IUBMB Life, 55, 661-668.
10. Chiti, F., Stefani, M., Taddei, N., Ramponi, G. and Dobson, C. M. (2003) Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature, 424, 805-808.
11. DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M. and Vendruscolo, M. (2004) Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol. 341, 1317-1326.
12. Pawar, A. P., Dubay, K. F., Zurdo, J., Chiti, F., Vendruscolo, M. and Dobson, C. M. (2005) Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases. J Mol Biol. 350, 379-392.
13. Fernandez-Escamilla, A. M., Rousseau, F., Schymkowitz, J. and Serrano, L. (2004) Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotechnol. 22, 1302-1306.
14. Lopez de la Paz, M. and Serrano, L. (2004) Sequence determinants of amyloid fibril formation. Proc Natl Acad Sci U S A. 101, 87-92.
15. Tartaglia, G. G., Pawar, A. P., Campioni, S., Dobson, C. M., Chiti, F. and Vendruscolo, M. (2008) Prediction of aggregation-prone regions in structured proteins. J Mol Biol. 380, 425-436.
16. Lansbury, P. T., Jr. (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci U S A. 96, 3342-3344.
17. Stefani, M. and Dobson, C. M. (2003) Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med. 81, 678-699.
18. Prusiner, S. B. (1998) Prions. Proc Natl Acad Sci U S A. 95, 13363-13383.
19. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M. and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature, 416, 507-511.
20. Bucciantini, M., Calloni, G., Chiti, F., Formigli, L., Nosi, D., Dobson, C. M. and Stefani, M. (2004) Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem. 279, 31374-31382.
21. Ward, R. V., Jennings, K. H., Jepras, R., Neville, W., Owen, D. E., Hawkins, J., Christie, G., Davis, J. B., George, A., Karran, E. H. and Howlett, D. R. (2000) Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide. Biochem J. 348, 137-144.
22. Novitskaya, V., Bocharova, O. V., Bronstein, I. and Baskakov, I. V. (2006) Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J Biol Chem. 281, 13828-13836.
23. Serpell, L. C., Sunde, M. and Blake, C. C. (1997) The molecular basis of amyloidosis. Cell Mol Life Sci. 53, 871-887.
24. Knowles, T. P., Fitzpatrick, A. W., Meehan, S., Mott, H. R., Vendruscolo, M., Dobson, C. M. and Welland, M. E. (2007) Role of intermolecular forces in defining material properties of protein nanofibrils. Science, 318, 1900-1903.
25. Smith, J. F., Knowles, T. P., Dobson, C. M., MacPhee, C. E. and Welland, M. E. (2006) Characterization of the nanoscale properties of individual amyloid fibrils. Proc Natl Acad Sci U S A.. 103, 15806-15811.
26. Sunde, M. and Blake, C. (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv Protein Chem. 50, 123-159.
27. Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B. and Blake, C. C. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J Mol Biol. 273, 729-739.
28. Jimenez, J. L., Guijarro, J. I., Orlova, E., Zurdo, J., Dobson, C. M., Sunde, M. and Saibil, H. R. (1999) Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18, 815-821.
29. Jimenez, J. L., Nettleton, E. J., Bouchard, M., Robinson, C. V., Dobson, C. M. and Saibil, H. R. (2002) The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci U S A. 99, 9196-9201.
30. Zhang, R., Hu, X., Khant, H., Ludtke, S. J., Chiu, W., Schmid, M. F., Frieden, C. and Lee, J. M. (2009) Interprotofilament interactions between Alzheimer's A{beta}1-42 peptides in amyloid fibrils revealed by cryoEM. Proc Natl Acad Sci U S A.
31. Klunk, W. E., Jacob, R. F. and Mason, R. P. (1999) Quantifying amyloid by congo red spectral shift assay. Methods Enzymol. 309, 285-305.
32. LeVine, H., 3rd (1999) Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 309, 274-284.
33. Krebs, M. R., Bromley, E. H. and Donald, A. M. (2005) The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol. 149, 30-37.
34. Dobson, C. M. (2003) Protein folding and misfolding. Nature, 426, 884-890.
35. Harper, J. D. and Lansbury, P. T., Jr. (1997) Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem. 66, 385-407.
36. Ecroyd, H., Koudelka, T., Thorn, D. C., Williams, D. M., Devlin, G., Hoffmann, P. and Carver, J. A. (2008) Dissociation from the oligomeric state is the rate-limiting step in amyloid fibril formation by kappa-casein. J Biol Chem. 283, 9012-9022.
37. Ecroyd, H. and Carver, J. A. (2009) Crystallin proteins and amyloid fibrils. Cell Mol Life Sci. 66, 62-81.
38. Meehan, S., Berry, Y., Luisi, B., Dobson, C. M., Carver, J. A. and MacPhee, C. E. (2004) Amyloid fibril formation by lens crystallin proteins and its implications for cataract formation. J Biol Chem. 279, 3413-3419.
39. Meehan, S., Knowles, T. P., Baldwin, A. J., Smith, J. F., Squires, A. M., Clements, P., Treweek, T. M., Ecroyd, H., Tartaglia, G. G., Vendruscolo, M., MacPhee, C. E., Dobson, C. M. and Carver, J. A. (2007) Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins. J Mol Biol. 372, 470-484.
40. Tanaka, N., Tanaka, R., Tokuhara, M., Kunugi, S., Lee, Y. F. and Hamada, D. (2008) Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin. Biochemistry, 47, 2961-2967.
41. Garvey, M., Gras, S. L., Meehan, S., Meade, S. J., Carver, J. A. and Gerrard, J. A. (2009) Protein nanofibres of defined morphology prepared from mixtures of crude crystallins. Int J Nanotech. 6, 258-273.
42. Papanikolopoulou, K., Mills-Henry, I., Thol, S. L., Wang, Y., Gross, A. A., Kirschner, D. A., Decatur, S. M. and King, J. (2008) Formation of amyloid fibrils in vitro by human gammaD-crystallin and its isolated domains. Mol Vis. 14, 81-89.
43. Sandilands, A., Hutcheson, A. M., Long, H. A., Prescott, A. R., Vrensen, G., Loster, J., Klopp, N., Lutz, R. B., Graw, J., Masaki, S., Dobson, C. M., MacPhee, C. E. and Quinlan, R. A. (2002) Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. EMBO J. 21, 6005-6014.
44. MacPhee, C. E. and Woolfson, D. N. (2004) Engineered and designed peptide-based fibrous biomaterials. Curr Opin Solid State Mat Sci. 8, 141-149.
45. Baldwin, A. J., Bader, R., Christodoulou, J., MacPhee, C. E., Dobson, C. M. and Barker, P. D. (2006) Cytochrome display on amyloid fibrils. J Am Chem Soc. 128, 2162-2163.
46. Gras, S. L. (2007) Amyloid fibrils: From disease to design. New biomaterial applications for self-assembling cross beta-fibrils. Aust J Chem. 60, 333-342.
47. Kelly, J. W. (1998) The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr Opin Struct Biol. 8, 101-106.
48. Uversky, V. N. and Fink, A. L. (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta, 1698, 131-153.
49. Carver, J. A., Aquilina, J. A., Truscott, R. J. and Ralston, G. B. (1992) Identification by 1H NMR spectroscopy of flexible C-terminal extensions in bovine lens alpha-crystallin. FEBS Lett. 311, 143-149.
50. Carver, J. A. and Lindner, R. A. (1998) NMR spectroscopy of alpha-crystallin. Insights into the structure, interactions and chaperone action of small heat-shock proteins. Int J Biol Macromol. 22, 197-209.
51. Sharma, K. K., Kumar, R. S., Kumar, G. S. and Quinn, P. T. (2000) Synthesis and characterization of a peptide identified as a functional element in alphaA-crystallin. J Biol Chem. 275, 3767-3771.
52. Reddy, G. B., Kumar, P. A. and Kumar, M. S. (2006) Chaperone-like activity and hydrophobicity of alpha-crystallin. IUBMB Life, 58, 632-641.
53. Hall, D., Hirota, N. and Dobson, C. M. (2005) A toy model for predicting the rate of amyloid formation from unfolded protein. J Mol Biol. 351, 195-205.
54. Hatters, D. M., MacPhee, C. E., Lawrence, L. J., Sawyer, W. H. and Howlett, G. J. (2000) Human apolipoprotein C-II forms twisted amyloid ribbons and closed loops. Biochemistry, 39, 8276-8283.
55. Hatters, D. M., MacRaild, C. A., Daniels, R., Gosal, W. S., Thomson, N. H., Jones, J. A., Davis, J. J., MacPhee, C. E., Dobson, C. M. and Howlett, G. J. (2003) The circularization of amyloid fibrils formed by apolipoprotein C-II. Biophys J. 85, 3979-3990.
56. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. and Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature, 418, 291.
57. Lashuel, H. A. and Lansbury, P. T., Jr. (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys. 39, 167-201.
58. Carver, J. A. (1999) Probing the structure and interactions of crystallin proteins by NMR spectroscopy. Prog Retin Eye Res. 18, 431-462.
59. Delaye, M. and Tardieu, A. (1983) Short-range order of crystallin proteins accounts for eye lens transparency. Nature, 302, 415-417.
60. Goldstein, L. E., Muffat, J. A., Cherny, R. A., Moir, R. D., Ericsson, M. H., Huang, X., Mavros, C., Coccia, J. A., Faget, K. Y., Fitch, K. A., Masters, C. L., Tanzi, R. E., Chylack, L. T., Jr. and Bush, A. I. (2003) Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet, 361, 1258-1265.
61. Derham, B. K. and Harding, J. J. (1999) Alpha-crystallin as a molecular chaperone. Prog Retin Eye Res. 18, 463-509.
62. Frederikse, P. H. (2000) Amyloid-like protein structure in mammalian ocular lenses. Curr Eye Res. 20, 462-468.
63. Fardeau, M., Godet-Guillain, J., Tome, F. M., Collin, H., Gaudeau, S., Boffety, C. and Vernant, P. (1978) A new familial muscular disorder demonstrated by the intra-sarcoplasmic accumulation of a granulo-filamentous material which is dense on electron microscopy (author's translation). Rev Neurol (Paris) 134, 411-425.
64. Vicart, P., Caron, A., Guicheney, P., Li, Z., Prevost, M. C., Faure, A., Chateau, D., Chapon, F., Tome, F., Dupret, J. M., Paulin, D. and Fardeau, M. (1998) A missense mutation in the alphaB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 20, 92-95.
65. Rajasekaran, N. S., Connell, P., Christians, E. S., Yan, L. J., Taylor, R. P., Orosz, A., Zhang, X. Q., Stevenson, T. J., Peshock, R. M., Leopold, J. A., Barry, W. H., Loscalzo, J., Odelberg, S. J. and Benjamin, I. J. (2007) Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell, 130, 427-439.
66. Maloyan, A., Gulick, J., Glabe, C. G., Kayed, R. and Robbins, J. (2007) Exercise reverses preamyloid oligomer and prolongs survival in alphaB-crystallin-based desmin-related cardiomyopathy. Proc Natl Acad Sci U S A.. 104, 5995-6000.
67. Sanbe, A., Osinska, H., Saffitz, J. E., Glabe, C. G., Kayed, R., Maloyan, A. and Robbins, J. (2004) Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc Natl Acad Sci U S A. 101, 10132-10136.
68. Maloyan, A., Sanbe, A., Osinska, H., Westfall, M., Robinson, D., Imahashi, K., Murphy, E. and Robbins, J. (2005) Mitochondrial dysfunction and apoptosis underlie the pathogenic process in alpha-B-crystallin desmin-related cardiomyopathy. Circulation, 112, 3451-3461.
69. Sanbe, A., Osinska, H., Villa, C., Gulick, J., Klevitsky, R., Glabe, C. G., Kayed, R. and Robbins, J. (2005) Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A. 102, 13592-13597.
70. Treweek, T. M., Rekas, A., Lindner, R. A., Walker, M. J., Aquilina, J. A., Robinson, C. V., Horwitz, J., Perng, M. D., Quinlan, R. A. and Carver, J. A. (2005) R120G alphaB-crystallin promotes the unfolding of reduced alpha-lactalbumin and is inherently unstable. FEBS J. 272, 711-724.
71. Sanbe, A., Yamauchi, J., Miyamoto, Y., Fujiwara, Y., Murabe, M. and Tanoue, A. (2007) Interruption of CryAB-amyloid oligomer formation by HSP22. J Biol Chem. 282, 555-563.
72. Renkawek, K., de Jong, W. W., Merck, K. B., Frenken, C. W., van Workum, F. P. and Bosman, G. J. (1992) alpha B-crystallin is present in reactive glia in Creutzfeldt-Jakob disease. Acta Neuropath. 83, 324-327.
73. Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T. and Kato, K. (1993) Alpha B crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimer's disease. J Neurol Sci. 119, 203-208.
74. McLean, P. J., Kawamata, H., Shariff, S., Hewett, J., Sharma, N., Ueda, K., Breakefield, X. O. and Hyman, B. T. (2002) TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J Neurochem. 83, 846-854.
75. Pountney, D. L., Treweek, T. M., Chataway, T., Huang, Y., Chegini, F., Blumbergs, P. C., Raftery, M. J. and Gai, W. P. (2005) Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy. Neurotox Res. 7, 77-85.
76. Wilhelmus, M. M., Otte-Holler, I., Wesseling, P., de Waal, R. M., Boelens, W. C. and Verbeek, M. M. (2006) Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol Appl Neurobiol. 32, 119-130.
77. Outeiro, T. F., Klucken, J., Strathearn, K. E., Liu, F., Nguyen, P., Rochet, J. C., Hyman, B. T. and McLean, P. J. (2006) Small heat shock proteins protect against alpha-synuclein-induced toxicity and aggregation. Biochem Biophys Res Commun. 351, 631-638.
78. Iwaki, T., Kume-Iwaki, A., Liem, R. K. and Goldman, J. E. (1989) Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain. Cell, 57, 71-78.
79. Ochi, N., Kobayashi, K., Maehara, M., Nakayama, A., Negoro, T., Shinohara, H., Watanabe, K., Nagatsu, T. and Kato, K. (1991) Increment of alpha B-crystallin mRNA in the brain of patient with infantile type Alexander's disease. Biochem Biophys Res Commun. 179, 1030-1035.
80. Kato, K., Inaguma, Y., Ito, H., Iida, K., Iwamoto, I., Kamei, K., Ochi, N., Ohta, H. and Kishikawa, M. (2001) Ser-59 is the major phosphorylation site in alphaB-crystallin accumulated in the brains of patients with Alexander's disease. J Neurochem. 76, 730-736.
81. Renkawek, K., Voorter, C. E., Bosman, G. J., van Workum, F. P. and de Jong, W. W. (1994) Expression of alpha B-crystallin in Alzheimer's disease. Acta Neuropath. 87, 155-160.
82. Iwaki, T., Wisniewski, T., Iwaki, A., Corbin, E., Tomokane, N., Tateishi, J. and Goldman, J. E. (1992) Accumulation of alpha B-crystallin in central nervous system glia and neurons in pathologic conditions. Am J Pathol. 140, 345-356.
83. Clark, J. I. and Muchowski, P. J. (2000) Small heat-shock proteins and their potential role in human disease. Curr Opin Struct Biol. 10, 52-59.
84. Fonte, V., Kapulkin, V., Taft, A., Fluet, A., Friedman, D. and Link, C. D. (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins. Proc Natl Acad Sci U S A.. 99, 9439-9444.
85. Fonte, V., Kipp, D. R., Yerg, J., 3rd, Merin, D., Forrestal, M., Wagner, E., Roberts, C. M. and Link, C. D. (2008) Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein. J Biol Chem. 283, 784-791.
86. Bilen, J. and Bonini, N. M. (2007) Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila. PLoS Genet. 3, 1950-1964.
87. Zourlidou, A., Payne Smith, M. D. and Latchman, D. S. (2004) HSP27 but not HSP70 has a potent protective effect against alpha-synuclein-induced cell death in mammalian neuronal cells. J Neurochem. 88, 1439-1448.
88. Mehlen, P., Schulze-Osthoff, K. and Arrigo, A. P. (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem. 271, 16510-16514.
89. Baek, S. H., Min, J. N., Park, E. M., Han, M. Y., Lee, Y. S., Lee, Y. J. and Park, Y. M. (2000) Role of small heat shock protein HSP25 in radioresistance and glutathione-redox cycle. J Cell Physiol. 183, 100-107.
90. Arrigo, A. P. (2001) Hsp27: novel regulator of intracellular redox state. IUBMB Life, 52, 303-307.
91. Yan, L. J., Christians, E. S., Liu, L., Xiao, X., Sohal, R. S. and Benjamin, I. J. (2002) Mouse heat shock transcription factor 1 deficiency alters cardiac redox homeostasis and increases mitochondrial oxidative damage. EMBO J. 21, 5164-5172.
92. Tabner, B. J., El-Agnaf, O. M., German, M. J., Fullwood, N. J. and Allsop, D. (2005) Protein aggregation, metals and oxidative stress in neurodegenerative diseases. Biochem Soc Trans. 33, 1082-1086.
93. Rekas, A., Adda, C. G., Aquilina, J. A., Barnham, K. J., Sunde, M., Galatis, D., Williamson, N. A., Masters, C. L., Anders, R. F., Robinson, C. V., Cappai, R. and Carver, J. A. (2004) Interaction of the molecular chaperone alphaB-crystallin with alpha-synuclein: effects on amyloid fibril formation and chaperone activity. J Mol Biol. 340, 1167-1183.
94. Rekas, A., Jankova, L., Thorn, D. C., Cappai, R. and Carver, J. A. (2007) Monitoring the prevention of amyloid fibril formation by alpha-crystallin. Temperature dependence and the nature of the aggregating species. FEBS J. 274, 6290-6304.
95. Wang, J., Martin, E., Gonzales, V., Borchelt, D. R. and Lee, M. K. (2008) Differential regulation of small heat shock proteins in transgenic mouse models of neurodegenerative diseases. Neurobiol Aging 29, 586-597.
96. Raman, B., Ban, T., Sakai, M., Pasta, S. Y., Ramakrishna, T., Naiki, H., Goto, Y. and Rao Ch, M. (2005) AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin. Biochem J. 392, 573-581.
97. Ecroyd, H., Meehan, S., Horwitz, J., Aquilina, J. A., Benesch, J. L., Robinson, C. V., MacPhee, C. E. and Carver, J. A. (2007) Mimicking phosphorylation of alphaB-crystallin affects its chaperone activity. Biochem J. 401, 129-141.
98. Ecroyd, H. and Carver, J. A. (2008) The effect of small molecules in modulating the chaperone activity of alphaB-crystallin against ordered and disordered protein aggregation. FEBS J. 275, 935-947.
99. Knowles, T. P., Shu, W., Devlin, G. L., Meehan, S., Auer, S., Dobson, C. M. and Welland, M. E. (2007) Kinetics and thermodynamics of amyloid formation from direct measurements of fluctuations in fibril mass. Proc Natl Acad Sci U S A. 104, 10016-10021.
100. Hatters, D. M., Lindner, R. A., Carver, J. A. and Howlett, G. J. (2001) The molecular chaperone, alpha-crystallin, inhibits amyloid formation by apolipoprotein C-II. J Biol Chem. 276, 33755-33761.
101. Stege, G. J., Renkawek, K., Overkamp, P. S., Verschuure, P., van Rijk, A. F., Reijnen-Aalbers, A., Boelens, W. C., Bosman, G. J. and de Jong, W. W. (1999) The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity. Biochem Biophys Res Commun. 262, 152-156.
102. Liang, J. J. (2000) Interaction between beta-amyloid and lens alphaB-crystallin. FEBS Lett. 484, 98-101.
103. Wilhelmus, M. M., Boelens, W. C., Otte-Holler, I., Kamps, B., de Waal, R. M. and Verbeek, M. M. (2006) Small heat shock proteins inhibit amyloid-beta protein aggregation and cerebrovascular amyloid-beta protein toxicity. Brain Res. 1089, 67-78.
104. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A. and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol. 15, 558-566.
105. Kumar, L. V. and Rao, C. M. (2000) Domain swapping in human alpha A and alpha B crystallins affects oligomerization and enhances chaperone-like activity. J Biol Chem. 275, 22009-22013.
106. Simon, S., Fontaine, J. M., Martin, J. L., Sun, X., Hoppe, A. D., Welsh, M. J., Benndorf, R. and Vicart, P. (2007) Myopathy-associated alphaB-crystallin mutants: abnormal phosphorylation, intracellular location, and interactions with other small heat shock proteins. J Biol Chem. 282, 34276-34287.
107. Litt, M., Kramer, P., LaMorticella, D. M., Murphey, W., Lovrien, E. W. and Weleber, R. G. (1998) Autosomal dominant congenital cataract associated with a missense mutation in the human alpha crystallin gene CRYAA. Hum Mol Genet. 7, 471-474.
108. Kumar, L. V., Ramakrishna, T. and Rao, C. M. (1999) Structural and functional consequences of the mutation of a conserved arginine residue in alphaA and alphaB crystallins. J Biol Chem. 274, 24137-24141.
109. Treweek, T. M., Ecroyd, H., Williams, D. M., Meehan, S., Carver, J. A. and Walker, M. J. (2007) Site-directed mutations in the C-terminal extension of human alphaB-crystallin affect chaperone function and block amyloid fibril formation. PLoS ONE, 2, e1046.
110. Arrigo, A. P., Simon, S., Gibert, B., Kretz-Remy, C., Nivon, M., Czekalla, A., Guillet, D., Moulin, M., Diaz-Latoud, C. and Vicart, P. (2007) Hsp27 (HspB1) and alphaB-crystallin (HspB5) as therapeutic targets. FEBS Lett. 581, 3665-3674.
111. Muchowski, P. J. (2002) Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron. 35, 9-12.
112. Carver, J. A., Lindner, R. A., Lyon, C., Canet, D., Hernandez, H., Dobson, C. M. and Redfield, C. (2002) The interaction of the molecular chaperone alpha-crystallin with unfolding alpha-lactalbumin: a structural and kinetic spectroscopic study. J Mol Biol. 318, 815-827.
113. Devlin, G. L., Carver, J. A. and Bottomley, S. P. (2003) The selective inhibition of serpin aggregation by the molecular chaperone, alpha-crystallin, indicates a nucleation-dependent specificity. J Biol Chem. 278, 48644-48650.